Epidermal Growth Factor Receptor (EGFR) Agonists:アゴニストのグローバル市場2015(薬開発、治験動向)

調査会社DelveInsight社が発行したリサーチレポート(データ管理コード:DIMRMOA5262)
◆英語タイトル:Epidermal Growth Factor Receptor (EGFR) Agonists -Pipeline Insights, 2015
◆発行会社/調査会社:DelveInsight
◆商品コード:DIMRMOA5262
◆発行日:2015年版(※最新版はお問い合わせください)
◆調査対象地域:グローバル
◆産業分野:製薬
◆ページ数:25以上
◆レポート言語:英語
◆レポート形式:PDF
◆納品方式:Eメール
◆販売価格オプション(消費税別)
Single UserUSD1,250 ⇒換算¥141,250見積依頼/購入/質問フォーム
Site Price(同一国内共有可)USD2,500 ⇒換算¥282,500見積依頼/購入/質問フォーム
Enterprise Price(複数国内共有可)USD4,000 ⇒換算¥452,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(振込先:三菱UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
DelveInsight社の概要及び新刊レポートはこちらでご確認いただけます。

★グローバルリサーチ資料[Epidermal Growth Factor Receptor (EGFR) Agonists:アゴニストのグローバル市場2015(薬開発、治験動向)]についてメールでお問い合わせはこちら
*** レポート概要(サマリー)***

DelveInsight’s,“Epidermal Growth Factor Receptor (EGFR) Agonists-Pipeline Insights, 2015”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key objective of the report is to establish the understanding for all the pipeline drugs that fall under Epidermal Growth Factor Receptor (EGFR) Agonists. This report provides information on the therapeutic development based on the Epidermal Growth Factor Receptor (EGFR) Agonists dealing with mechanism of action, comparative analysis at various stages covering Filed, Phase III, Phase II, Phase I, IND filed, Preclinical, Discovery and unknown stages, therapeutics assessment by monotherapy and combination products and molecule type drug information. The report also covers the companies information involved in the therapeutic development of the products. It also has highlighted the discontinued and dormant products.

[Data Sources]

The report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by DelveInsight team of industry experts.

Secondary sources information and data has been collected from various printable and non-printable sources like search engines, News websites, Government Websites, Trade Journals, White papers, Magazines, Trade associations, Books, Industry Portals, Industry Associations and access to available databases.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated mechanism of action.


• The report provides a snapshot of the global therapeutic landscape of Epidermal Growth Factor Receptor (EGFR) Agonists
• The report provides pipeline products under drug profile section which includes product description, MOA, licensors & collaborators, development partner and chemical information
• Coverage of the Epidermal Growth Factor Receptor (EGFR) Agonists pipeline on the basis of target, MOA, route of administration, technology involved and molecule type
• The report reviews key players involved in the therapeutics development for Epidermal Growth Factor Receptor (EGFR) Agonists and also provide company profiling
• The report also gives the information of dormant and discontinued pipeline projects
• Pipeline products coverage based on various stages of development ranging from preregistration till discovery and undisclosed stages
• Provides pipeline assessment by monotherapy and combination therapy products, stage of development and molecule type

*** レポート目次(コンテンツ)***

• Epidermal Growth Factor Receptor (EGFR) Agonists Overview
• Epidermal Growth Factor Receptor (EGFR) Agonists Disease Associated
• Epidermal Growth Factor Receptor (EGFR) Agonists Pipeline Therapeutics
• Epidermal Growth Factor Receptor (EGFR) Agonists Therapeutics under Development by Companies
• Epidermal Growth Factor Receptor (EGFR) Agonists Late Stage Products (Filed and Phase III)
• Comparative Analysis
• Epidermal Growth Factor Receptor (EGFR) Agonists Mid Clinical Stage Products (Phase II)
• Comparative Analysis
• Epidermal Growth Factor Receptor (EGFR) Agonists Early Clinical Stage Products (Phase I and IND Filed)
• Comparative Analysis
• Epidermal Growth Factor Receptor (EGFR) Agonists Discovery and Pre-Clinical Stage Products
• Comparative Analysis
• Drug Candidate Profiles
• Epidermal Growth Factor Receptor (EGFR) Agonists – Therapeutics Assessment
• Assessment by Monotherapy Products
• Assessment by Combination Products
• Assessment by Route of Administration
• Assessment by Molecule Type
• Epidermal Growth Factor Receptor (EGFR) Agonists – Discontinued Products
• Epidermal Growth Factor Receptor (EGFR) Agonists – Dormant Products
• Companies Involved in Therapeutics Development for Epidermal Growth Factor Receptor (EGFR) Agonists
• Appendix
• Methodology
• Contact Us
• Disclaimer

• Number of Products under Development for Epidermal Growth Factor Receptor (EGFR) Agonists by Therapy Area, 2015
• Number of Products under Development for Epidermal Growth Factor Receptor (EGFR) Agonists, 2015
• Number of Products under Development by Companies
• Comparative Analysis by Late Clinical Stage Products (Filed and Phase III), 2015
• Comparative Analysis Mid Clinical Stage Products (Phase II), 2015
• Comparative Analysis Early Clinical Stage Products (Phase I and IND Filed), 2015
• Comparative Analysis Discovery and Pre-Clinical Stage Products, 2015
• Drug Candidates Profiles
• Epidermal Growth Factor Receptor (EGFR) Agonists Assessment by Monotherapy Products
• Epidermal Growth Factor Receptor (EGFR) Agonists Assessment by Combination Products
• Epidermal Growth Factor Receptor (EGFR) Agonists Assessment by Route of Administration
• Epidermal Growth Factor Receptor (EGFR) Agonists Assessment by Stage and Route of Administration
• Epidermal Growth Factor Receptor (EGFR) Agonists Assessment by Molecule Type
• Epidermal Growth Factor Receptor (EGFR) Agonists Assessment by Stage and Molecule Type
• Epidermal Growth Factor Receptor (EGFR) Agonists Therapeutics – Discontinued Products
• Epidermal Growth Factor Receptor (EGFR) Agonists Therapeutics – Dormant Products
• Products under Development by Companies, 2015

• Number of Products under Development for Epidermal Growth Factor Receptor (EGFR) Agonists by Therapy Area, 2015
• Number of Products under Development for Epidermal Growth Factor Receptor (EGFR) Agonists, 2015
• Late Clinical Stage Products (Filed and Phase III), 2015
• Mid Clinical Stage Products (Phase II), 2015
• Early Clinical Stage Products (Phase I and IND Filed), 2015
• Discovery and Pre-Clinical Stage Products, 2015
• Epidermal Growth Factor Receptor (EGFR) Agonists Assessment by Monotherapy Products
• Epidermal Growth Factor Receptor (EGFR) Agonists Assessment by Combination Products
• Epidermal Growth Factor Receptor (EGFR) Agonists Assessment by Route of Administration
• Epidermal Growth Factor Receptor (EGFR) Agonists Assessment by Stage and Route of Administration
• Epidermal Growth Factor Receptor (EGFR) Agonists Assessment by Molecule Type
• Epidermal Growth Factor Receptor (EGFR) Agonists Assessment by Stage and Molecule Type

*** レポートのキーワード ***

薬剤、医薬品、製薬企業、試験、作用機序(MOA)、パイプライン、開発

*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/


※おすすめ調査資料
  • 世界及び中国のエナメル銅線市場2016
    The 'Global and Chinese Enamelled Copper Wire Industry, 2011-2021 Market Research Report' is a professional and in-depth study on the current state of the global Enamelled Copper Wire industry with a focus on the Chinese market. The report provides key statistics on the market status of the Enamelle …
  • 世界及び中国のピロリン酸第2鉄ミクロ2市場2016
    The 'Global and Chinese Ferric Pyrophosphate Micro2 Industry, 2011-2021 Market Research Report' is a professional and in-depth study on the current state of the global Ferric Pyrophosphate Micro2 industry with a focus on the Chinese market. The report provides key statistics on the market status of …
  • 世界及び中国のヒアルロン酸市場2017
    The 'Global and Chinese Hyaluronic Acid Industry, 2012-2022 Market Research Report' is a professional and in-depth study on the current state of the global Hyaluronic Acid industry with a focus on the Chinese market. The report provides key statistics on the market status of the Hyaluronic Acid manu …
  • 世界及び中国のクエン酸タモキシフェン市場2017
    The 'Global and Chinese Tamoxifen citrate Industry, 2012-2022 Market Research Report' is a professional and in-depth study on the current state of the global Tamoxifen citrate industry with a focus on the Chinese market. The report provides key statistics on the market status of the Tamoxifen citrat …
  • アリルグリシジルエーテルの世界市場2014
    Ally Glycidyl Ether (CAS 106-92-3) Market Research Report 2014 aims at providing comprehensive data on Ally Glycidyl Ether market globally and regionally (Europe, Asia, North America, Latin America etc.) The report includes Ally Glycidyl Ether description, covers its application areas, manufacturing …
  • 世界のデジタル油田ソリューション市場2016
    2016 Global Digital Oilfield Solutions Industry Report is a professional and in-depth research report on the world's major regional market conditions of the Digital Oilfield Solutions industry, focusing on the main regions (North America, Europe and Asia) and the main countries (United States, Germa …
  • ポリテトラフルオロエチレンの世界市場2014
    Polytetrafluoroethylene (CAS 9002-84-0) Market Research Report 2014 aims at providing comprehensive data on Polytetrafluoroethylene market globally and regionally (Europe, Asia, North America, Latin America etc.) The report includes Polytetrafluoroethylene description, covers its application areas, …
  • 消費者のスマートフォン利用2014:アプリケーション及びサービス利用におけるデバイスモデルの影響
    This report analyses how smartphone specifications and manufacturer strategies affect app usage. The analysis is based on real-world smartphone usage of consumers in France, Germany, the UK and the USA between August and October 2013, using data provided by Nielsen.
  • 世界のキッティング触輪市場2017
    Kitting Trolleys Report by Material, Application, and Geography – Global Forecast to 2021 is a professional and in-depth research report on the world's major regional market conditions, focusing on the main regions (North America, Europe and Asia-Pacific) and the main countries (United States, Germa …
  • 単層カーボンナノチューブの世界市場:販売動向2017
    Notes:Sales, means the sales volume of Single-wall Carbon Nanotube Revenue, means the sales value of Single-wall Carbon Nanotube This report studies sales (consumption) of Single-wall Carbon Nanotube in Global market, especially in United States, China, Europe and Japan, focuses on top players in th …
※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
※当市場調査資料(DIMRMOA5262 )"Epidermal Growth Factor Receptor (EGFR) Agonists:アゴニストのグローバル市場2015(薬開発、治験動向)" (英文:Epidermal Growth Factor Receptor (EGFR) Agonists -Pipeline Insights, 2015)はDelveInsight社が調査・発行しており、H&Iグローバルリサーチが販売します。


◆H&Iグローバルリサーチのお客様(例)◆


※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
※H&Iグローバルリサーチ(登録第5864124号)及びH&I(登録第5783645号)はH&Iグローバルリサーチ株式会社の商標です。